The Scientific Advisory Board meets with the Director of the CDD once a year, and offers guidance on the Center’s long-term planning and goals.

The CDD is excited to welcome Dr. Steve Gilman of CUBIST Pharmaceuticals to its Scientific Advisory Board. Dr. Gilman was inducted at the Board meeting on December 19, 2013.

Scientific Advisory Board Members

Steven C. Gilman, Executive Vice President and Chief Scientific Officer
CUBIST Pharmaceuticals

Andreas Goutopoulos, Director of Chemistry
EMD Serono

Peter Isakson, Former Divisional Vice-President, Immunology Research
Abbot Bioresearch Center

George Kunos, Scientific Director of NIAAA & Senior Investigator of Neuroscience
National Institutes of Health

James Kyranos, Vice President of Chemical Technology
Forma Therapeutics

Anna Protopapas, President and CEO
Mersana Therapeutics

Tomi Sawyer, Founding CSO and Senior Vice President of Drug Discovery & Innovative Technologies
Aileron Therapeutics

Peter Schiller, Directeur, Biologie Chimique et des Polypeptides
Institut de Recherches Cliniques de Montréal

Charles Serhan, the Simon Gelman Professor of Anesthesia, Perioperative and Pain Medicine
Center for Experimental Therapeutics and Reperfusion Injury, Harvard Medical School